The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature

BMC Infect Dis. 2016 Jun 14:16:293. doi: 10.1186/s12879-016-1633-9.

Abstract

Background: Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer in women and their provision remains a major public health need. However, HPV is also a major cause of non-cervical anogenital and oropharyngeal cancers and the potential benefit of vaccination likely extends beyond cervical cancer.

Methods: A systematic literature search of PubMed (1995-2014) identified publications assessing the incidence, persistence, and clearance of non-cervical anogenital/oral HPV infections. Comparability with cervical HPV was assessed by identifying articles assessing the same or similar populations.

Results: Available data suggest high incidence rates of non-cervical HPV infection in men and women, with HPV-16 predominating in all sites. The incidence of high risk HPV per 100 person-years ranged from 11.4 to 72.9 for penile infections, 6.7-47.9 at other male genital sites, and 4.4-36.7 and 5.3-23.4 for anal infections in men and women, respectively. The incidence per 100 person-years of oral infection with any HPV type ranged from 5.7 to 6.7 in men and 6.8-39.6 in women. Within the limitations of the data, there was a general pattern of higher incidence and clearance of non-cervical genital HPV infections, compared to cervical infections. HIV status, circumcision, number of sex partners and partner HPV status significantly influenced high-risk HPV incidence/clearance at male anogenital sites. Few studies assessed risk factors for oral HPV.

Conclusions: Parallels appear to exist between the epidemiology of cervical and non-cervical HPV infections in terms of incidence, HPV-type distribution, and risk factors for infection. Available data suggest that non-cervical genital HPV infections may occur more frequently, with higher clearance rates, than cervical infections. More extensive studies could provide useful information for estimating vaccine impact, the wider cost-benefit of HPV vaccination, and guiding vaccination policy.

Trial registration: Not applicable, as systematic review of the literature.

Keywords: Cervical; Clearance; Human papillomavirus; Incidence; Oral; Penile; Persistence; Systematic review; Vaginal.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Anus Diseases / epidemiology*
  • Anus Diseases / virology
  • Female
  • Genital Diseases, Male / epidemiology*
  • Genital Diseases, Male / virology
  • Human papillomavirus 16
  • Humans
  • Incidence
  • Male
  • Mouth Diseases / epidemiology*
  • Mouth Diseases / virology
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / virology
  • Papillomavirus Vaccines
  • Sexual Partners
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / virology
  • Vaginal Diseases / epidemiology*
  • Vaginal Diseases / virology

Substances

  • Papillomavirus Vaccines